Patents Represented by Attorney, Agent or Law Firm Ilene Janofsky
-
Patent number: 6171251Abstract: Computer controlled apparatus and method for enhancing myocardial revascularization using direct vessel implants includes a probe for insertion into a proposed graft site to determine the condition of the site using criteria such as oxygen levels, contractility and pressure/flow rate differentials in conjunction with the parameters of the selected vessel graft. Transmyocardial revascularization procedures are performed to increase flow rates when needed and to supplement graft treatment where desired. A coring device creates the opening for the graft and correlates the size of the opening with contractility conditions and vessel conditions. Reinforcement sleeves may be placed around grafts, particularly vein grafts, to avoid excess compression of the graft. Graft site preparation and TMR treatment enhance angiogenesis and collateralization of the implant, and angiogenic drugs may be used to increase such effects.Type: GrantFiled: July 14, 1998Date of Patent: January 9, 2001Assignee: Eclipse Surgical Technologies, Inc.Inventors: Richard L. Mueller, Michael J. Rosinko
-
Patent number: 5288499Abstract: Methods and compositions are described for the preparation of bioactive agents entrapped in lipid vesicles the bilayers of which comprise a salt form of an organic acid derivative of a sterol, such as the tris-salt form of a sterol hemisuccinate, and to compositions comprising a mixture of tris(hydroxymethyl)aminomethane salt of cholesteryl hemisuccinate with either an antifungal compound or a peptide. These compositions have various applications in vivo.Type: GrantFiled: September 12, 1991Date of Patent: February 22, 1994Assignee: The Liposome Company, Inc.Inventors: Andrew S. Janoff, Mircea C. Popescu, Alan L. Weiner, Lois E. Bolcsak, Paul A. Tremblay, Christine E. Swenson
-
Patent number: 5234634Abstract: Methods and compositions are described for the preparation of alpha-tocopherol vesicles, the bilayers of which comprise a salt form of an organic acid derivative of alpha-tocopherol such as the Tris salt form of alpha-tocopherol hemisuccinate. The method is rapid and efficient and does not require the use of organic solvents. The alpha-tocopherol vesicles may be used to entrap compounds which are insoluble in aqueous solutions. Such preparations are especially useful for entrapping bioactive agents of limited solubility, thus enabling administration in vivo.Type: GrantFiled: October 17, 1990Date of Patent: August 10, 1993Assignee: The Liposome Company, Inc.Inventors: Andrew S. Janoff, Lois E. Bolcsak, Alan L. Weiner, Paul A. Tremblay, Michael V. W. Bergamini
-
Patent number: 5231112Abstract: Methods and compositions are described for the preparation of bioactive agents entrapped in lipid vesicles the bilayers of which comprise a salt form of an organic acid derivative of a sterol, such as the tris-salt form of a sterol hemisuccinate, and to bompositions comprising a mixture of tris(hydroxymethyl)aminomethane salt of cholesteryl hemisuccinate with either an antifungal compound or a peptide. These compositions have various applications in vivo.Type: GrantFiled: October 23, 1989Date of Patent: July 27, 1993Assignee: The Liposome Company, Inc.Inventors: Andrew S. Janoff, Mircea C. Popescu, Alan L. Weiner, Lois E. Bolcsak, Paul A. Tremblay, Christine E. Swenson
-
Patent number: 5188951Abstract: A method of preparing a soluble monovalent salt of a phosphatidyl ester which comprises reacting a phospholipid with a primary alcohol in the presence of an enzyme catalyst in a divalent cationic buffered solution and a water immiscible non-ether solvent that does not inactivate the enzyme, to form a divalent cationic salt of the phosphatidyl ester, and suspending the product in the presence of a stoichiometric amount of a monovalent cationic salt whose anion forms an insoluble salt with the divalent cation. The use of Centrifugal Partition Chromatography facilitates the enzyme reaction. The monovalent salt is preferably an ammonium/sodium mixed salt.Type: GrantFiled: May 1, 1991Date of Patent: February 23, 1993Assignee: The Liposome Company, Inc.Inventors: Paul-Alain Tremblay, Frank Marziani, John A. F. Tino, Frank G. Pilkiewicz
-
Patent number: 5171737Abstract: A novel oil and water emulsion useful for delivery of a bioactive agent is disclosed. The emulsion comprises a first HLB requirement amount of surfactant dioleoyl phosphatidylethanolamine. In particular embodiments the emulsion includes a secondary surfactant other than dioleoyl phosphatidylethanolamine except in the limiting case wherein the HLB requirement is the HLB value of dioleoyl phosphatidylethanolamine in which case the HLB requirement amount of a secondary surfactant is 0. By appropriate selection of dioleoyl phosphatidylethanolamine to secondary surfactant ratios, it is possible to prepare emulsions for pharmaceutical delivery of a bioactive agent using an oil phase having a required HLB value up to about 17.4. Above a required HLB value of about 17.4. dioleoyl phosphatidylethanolamine may be used to reduce the amount of secondary surfactant required to form an emulsion.Type: GrantFiled: March 3, 1989Date of Patent: December 15, 1992Assignee: The Liposome Company, Inc.Inventors: Alan L. Weiner, Sharon Carpenter-Green
-
Patent number: 5154930Abstract: A pharmacological agent-lipid solution preparation comprising a lipophilic pharmacological agent, a desalted charged lipid and an aqueous-miscible lipid solvent such that upon introduction into an aqueous medium a suspension of lipid aggregates associated with the pharmacological agent are formed, and methods of manufacture and use.Type: GrantFiled: February 25, 1988Date of Patent: October 13, 1992Assignee: The Liposome Company, Inc.Inventors: Mircea C. Popescu, Paul A. Tremblay, Andrew S. Janoff, Marc J. Ostro, Elaine Chan, Alan Weiner
-
Patent number: 5041278Abstract: Methods and compositions are described for the preparation of alpha-tocopherol vesicles, the bilayers of which comprise a salt form of an organic acid derivative of alpha-tocopherol such as the Tris salt form of alpha-tocopherol hemisuccinate. The method is rapid and efficient and does not require the use of organic solvents. The alpha-tocopherol vesicles may be used to entrap compounds which are insoluble in aqueous solutions. Such preparations are especially useful for entrapping bioactive agents of limited solubility, thus enabling administration in vivo.Type: GrantFiled: December 6, 1988Date of Patent: August 20, 1991Assignee: The Liposome Company, Inc.Inventors: Andrew S. Janoff, Lois E. Bolcsak, Alan L. Weiner, Paul A. Tremblay, Michael V. W. Bergamini